Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cvitkovic

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
A call for change in anticancer drug evaluationE Cvitkovic
British Journal of Cancer|July 1, 1998
Ongoing and unsaid on oxaliplatin: the hopeE Cvitkovic
Seminars in Oncology|December 22, 1999
Oxaliplatin: a new therapeutic option in colorectal cancerE Cvitkovic, M Bekradda
Bulletin Du Cancer|March 6, 1999
[Phase III trials in oncology]K Imadalou, E Cvitkovic
Drugs|January 1, 1992
The current and future place of vinorelbine in cancer therapyE Cvitkovic, J Izzo
Current Opinion in Oncology|May 1, 1995
Biology and treatment of nasopharyngeal cancerA Fandi, E Cvitkovic
Bulletin Du Cancer|September 25, 2001
[Oxaliplatin: a first DACH-platinum in oncology]A Laadem, E Cvitkovic
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
Characterisation and clinical management of CPT-11 (irinotecan)-induced adverse events: the European perspectiveH Bleiberg, E Cvitkovic
Anti-Cancer Drugs|December 13, 1997
Role of vindesine as neoadjuvant chemotherapy for non-small cell lung and head and neck cancersE Cvitkovic, E Wasserman
Clinical Colorectal Cancer|November 27, 2002
Irinotecan plus oxaliplatin: a promising combination for advanced colorectal cancerE Wasserman, W Sutherland, E Cvitkovic
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
A call for change in anticancer drug evaluationE Cvitkovic
British Journal of Cancer|July 1, 1998
Ongoing and unsaid on oxaliplatin: the hopeE Cvitkovic
Seminars in Oncology|December 22, 1999
Oxaliplatin: a new therapeutic option in colorectal cancerE Cvitkovic, M Bekradda
Bulletin Du Cancer|March 6, 1999
[Phase III trials in oncology]K Imadalou, E Cvitkovic
Drugs|January 1, 1992
The current and future place of vinorelbine in cancer therapyE Cvitkovic, J Izzo
Current Opinion in Oncology|May 1, 1995
Biology and treatment of nasopharyngeal cancerA Fandi, E Cvitkovic
Bulletin Du Cancer|September 25, 2001
[Oxaliplatin: a first DACH-platinum in oncology]A Laadem, E Cvitkovic
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
Characterisation and clinical management of CPT-11 (irinotecan)-induced adverse events: the European perspectiveH Bleiberg, E Cvitkovic
Anti-Cancer Drugs|December 13, 1997
Role of vindesine as neoadjuvant chemotherapy for non-small cell lung and head and neck cancersE Cvitkovic, E Wasserman
Clinical Colorectal Cancer|November 27, 2002
Irinotecan plus oxaliplatin: a promising combination for advanced colorectal cancerE Wasserman, W Sutherland, E Cvitkovic
Pageof 13